Literature DB >> 8649865

Soft tissue sarcoma metastasis from clonal expansion of p53 mutated tumor cells.

R E Pollock1, A Lang, J Luo, A K El-Naggar, D Yu.   

Abstract

Although soft tissue sarcoma has a high incidence of p53 mutations, it is not clear if such alterations facilitate tumor growth and metastasis. In this study, fresh autologous normal lymphocytes, normal muscle, primary and metastatic sarcoma tissues from a single synovial sarcoma patient were examined for p53-related alterations that potentially associated with sarcoma tumor development and metastasis. Normal tissues contain two wild-type p53 alleles. Primary sarcoma had one chromosome 17p p53 allelic deletion without apparent p53 mutation in the other allele. However, metastatic tumor had deletion of one p53 allele with an exon 5 codon 135 missense mutation in the other allele. This p53 gene point mutation in the metastasis was associated with the production of mutated p53 protein. A small clone of cells harboring the identical p53 gene point mutation was identified in the primary tumor using mutant allele specific PCR amplification, albeit at levels much less than in the metastatic sarcoma. This single patient example indicate that soft tissue sarcoma metastasis can develop from clonal expansion of primary tumor cells bearing p53 mutations.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8649865

Source DB:  PubMed          Journal:  Oncogene        ISSN: 0950-9232            Impact factor:   9.867


  9 in total

1.  Limitations of the use of single base changes in the p53 gene to detect minimal residual disease of breast cancer.

Authors:  R K B Dang; R S Anthony; J I O Craig; R C F Leonard; A C Parker
Journal:  Mol Pathol       Date:  2002-06

2.  High Frequency of p53/MDM2/p14ARF Pathway Abnormalities in Relapsed Neuroblastoma.

Authors:  Jane Carr-Wilkinson; Kieran O'Toole; Katrina M Wood; Christine C Challen; Angela G Baker; Julian R Board; Laura Evans; Michael Cole; Nai-Kong V Cheung; Joachim Boos; Gabriele Köhler; Ivo Leuschner; Andrew D J Pearson; John Lunec; Deborah A Tweddle
Journal:  Clin Cancer Res       Date:  2010-02-09       Impact factor: 12.531

3.  p-AKT overexpression in primary renal cell carcinomas and their metastases.

Authors:  Martina Hager; Heike Haufe; Lukas Lusuardi; Nikolaus Schmeller; Christian Kolbitsch
Journal:  Clin Exp Metastasis       Date:  2010-09-16       Impact factor: 5.150

Review 4.  Myxoid liposarcoma originating in the retroperitoneum with metastasis to the calcaneus: a rare case report and review of literature.

Authors:  Kazuhiko Hashimoto; Shunji Nishimura; Seiichiro Mitani; Tomohiko Ito; Masao Akagi
Journal:  Skeletal Radiol       Date:  2022-03-06       Impact factor: 2.128

5.  Comparison of Akt/mTOR signaling in primary breast tumors and matched distant metastases.

Authors:  Argun Akcakanat; Aysegul Sahin; Alexandra N Shaye; Marco A Velasco; Funda Meric-Bernstam
Journal:  Cancer       Date:  2008-06       Impact factor: 6.860

6.  Metastatic patterns of myxoid/round cell liposarcoma: a review of a 25-year experience.

Authors:  Naofumi Asano; Michiro Susa; Seiichi Hosaka; Robert Nakayama; Eisuke Kobayashi; Katsuhito Takeuchi; Keisuke Horiuchi; Yoshihisa Suzuki; Ukei Anazawa; Makio Mukai; Yoshiaki Toyama; Hiroo Yabe; Hideo Morioka
Journal:  Sarcoma       Date:  2012-04-01

7.  Prognostic significance of bcl-2 expression in leiomyosarcoma of the uterus.

Authors:  Y L Zhai; T Nikaido; T Toki; A Shiozawa; A Orii; S Fujii
Journal:  Br J Cancer       Date:  1999-07       Impact factor: 7.640

8.  Enhanced MDM2 Oncoprotein Expression in Soft Tissue Sarcoma: Several Possible Regulatory Mechanisms.

Authors:  R E Pollock; A Lang; A K El-Naggar; R Radinsky; M C Hung
Journal:  Sarcoma       Date:  1997

9.  Next generation sequencing in synovial sarcoma reveals novel gene mutations.

Authors:  Myrella Vlenterie; Melissa H S Hillebrandt-Roeffen; Uta E Flucke; Patricia J T A Groenen; Bastiaan B J Tops; Eveline J Kamping; Rolph Pfundt; Diederik R H de Bruijn; Ad H M Geurts van Kessel; Han J H J M van Krieken; Winette T A van der Graaf; Yvonne M H Versleijen-Jonkers
Journal:  Oncotarget       Date:  2015-10-27
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.